Metabolic-Fit / 100
VevaRX review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Its own semaglutide page gives two different prices for the same product. The pricing cards read $189 a month or $399 for three months, and the paragraph directly beneath them reads $167 a month or $467 for three — and since $467 is the tirzepatide total, the text appears to be leftover copy from the other product. The tirzepatide page has an arithmetic problem of its own, advertising $467 as equivalent to $149 a month when three months at $467 is $155.67, and there is no monthly tirzepatide plan at all: a three-month minimum applies and the plan renews every three months. The terms then compound it by referring repeatedly to a different company's website and listing prices that match nothing on the product pages. What is genuinely strong is easy to miss underneath all that. VevaRX enumerates thirty-six states by name rather than claiming fifty, it locks the price before intake and holds it at every dose, and the quoted figure includes the provider visit, the supplies and free two-to-three-day shipping.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
VevaRX at a glance
- Semaglutide
- $189/mo
- Tirzepatide
- $155.67/mo, sold only as a 3-month plan
- Coverage
- 36 states, enumerated
- Brand-name
- Compounded only
How we scored VevaRX
Every factor comes from VevaRX's own published pricing, disclosures and oversight, and the six combine into the 31/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
Its own semaglutide page gives two different prices for the same product. The cards say $189 a month or $399 for three months; the paragraph directly beneath them says $167 a month or $467 for three — and $467 is the tirzepatide price, so the text appears to be left over from the other product. The tirzepatide page has its own arithmetic problem: it advertises $467 as equivalent to $149 a month when three months of $467 is $155.67. There is no monthly tirzepatide plan at all, only a three-month minimum that renews every three months. The terms then refer repeatedly to a different company's website. Thirty-six states are listed by name, which is a real strength.
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $189 | Monthly planThe monthly card on the semaglutide page. The prose lower down the same page says the monthly program is $167, so the site gives two different monthly prices for one product. |
| Compounded semaglutide | $133 | 3-month plan, one charge of $399Labeled best value and "Equivalent to $133/month". The prose below it instead describes a 3-month program at $467, which is the tirzepatide total. |
| Compounded tirzepatide | $156 | 3-month plan, one charge of $467 — the only optionAdvertised as "Equivalent to $149 per month", but $467 across three months is $155.67. There is no monthly tirzepatide plan; a three-month minimum applies and it renews every three months. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what VevaRX's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Thirty-six states enumerated by name rather than an unverifiable fifty-state claim
- The price is locked in before intake and holds at every dose
- The quoted figure includes the provider visit, supplies and free two-to-three-day shipping
- A monthly semaglutide plan now exists alongside the three-month one
The caveats
- The semaglutide page states two different monthly prices, $189 and $167, for the same product
- It also states two different three-month totals, $399 and $467, one of which is the tirzepatide price
- Tirzepatide is advertised as $149 a month when $467 over three months is $155.67
- There is no monthly tirzepatide option — a three-month minimum applies and renews every three months
- The terms repeatedly reference a different company's website and list prices matching no product page
- No compounding pharmacy is named, and nothing addresses pregnancy, breastfeeding or postpartum timing
The price cards and explanatory text disagree
VevaRX's semaglutide page presents a $189 monthly card and a $399 three-month card, equivalent to $133 per month. The explanatory paragraph on the same page instead describes $167 monthly and $467 for three months. Those figures cannot all describe the same current offer. A prospective patient should request one written semaglutide quote that identifies which plan applies, the amount due immediately and the amount due at renewal. Choosing the lowest number on the screen would conceal rather than resolve the problem.
Tirzepatide has a different issue. Its three-month total is $467, yet the page calls that equivalent to $149 monthly. Dividing $467 by three gives approximately $155.67. The published plan has a three-month minimum and renews every three months; it is not a flexible $149 monthly subscription. That full commitment matters more than the rounded comparison figure. Ask whether the amount is collected in one payment, how much medication is supplied and when a cancellation must arrive to stop the next three-month charge.
Some service details are clearer than the pricing
VevaRX says the quoted treatment includes a provider visit, supplies and free two-to-three-day shipping when a prescription is approved. It also describes locking the price before intake and keeping the same price across doses. Those can be useful protections, provided the amount actually locked is unambiguous. The contradictory semaglutide figures make a written confirmation particularly valuable. A dose-flat promise does not help a patient choose between two competing monthly amounts or determine which three-month total is the one the company intends to collect.
Coverage is described through thirty-six individually named states, which offers a practical way to establish eligibility before starting. The company identifies VevaRx LLC in its privacy notice but says it is not a pharmacy, with medication dispensed by a licensed pharmacy when prescribed. No specific compounding pharmacy is named in the available information. Ask who will prepare the prescription and what the formulation contains. State coverage, corporate identity and pharmacy identity are related parts of the purchase, but none substitutes for the others.
Read the agreement against the chosen product
The Terms repeatedly reference another website and list prices that do not match the product pages. That is a document-accuracy concern, not evidence that the companies share ownership. For a customer it creates a concrete question: which agreement governs the selected VevaRX plan and which amount will it authorize? Obtain an answer before relying on a cancellation sentence or assuming that the checkout will reconcile conflicting public pages. A clear final payment screen is useful, but it should align with an understandable agreement rather than silently choose among several prices.
VevaRX does not provide substantive public guidance on pregnancy, breastfeeding or postpartum timing. A mother seeking that care needs a personalized conversation and an explanation of how the prescriber coordinates with existing clinicians. The three-month tirzepatide structure may suit someone comfortable with a continuing commitment, while a genuinely confirmed monthly semaglutide option may offer more flexibility. The service's included visit and shipping are relevant strengths, but the central decision comes first: obtain a consistent treatment price, renewal schedule, governing terms and pharmacy identity before making the initial payment.
The bottom line for mothers
Best for: Someone who wants a price fixed before intake and held at every dose, and who will get the monthly figure confirmed in writing given that the page states two.
Alternatives to VevaRX
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Enhance MD81
Metabolic-Fit / 100
A compounded program that advertises ongoing provider care, metabolic testing every six months and shipping within its price. Semaglutide is $249 and tirzepatide $329 every four weeks without a longer commitment; lower equivalents require 12-, 24- or 48-week terms. Microdose and combination options need separate current quotes.
- Visit Embody41
Metabolic-Fit / 100
Compounded medication with clinician access and coaching, with semaglutide shown at $299 regular and $79 on a time-limited sale. The important commitment comes before the eligibility decision: payment is taken first, paid terms are generally non-refundable, and medical disqualification refunds only the unused portion after deductions.
Providers like VevaRX
Keep comparing VevaRX
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
VevaRX, answered
- What does semaglutide actually cost here?
- The page gives two answers. Its pricing cards say $189 a month or $399 for a three-month plan, and the paragraph immediately below them says $167 a month or $467 for three months. The $467 is the tirzepatide total, so the text looks like leftover copy from the other product. Until VevaRX corrects it, get the figure confirmed in writing before you pay anything.
- Is tirzepatide really $149 a month?
- No. The plan costs $467 for three months, which is $155.67 a month, not the $149 the page advertises beside it. It is a small gap but it is the seller's own arithmetic on its own product page, and there is no monthly option to compare it against — a three-month minimum applies and the plan renews every three months.
- Why do the terms mention another company?
- That is a fair question to put to them. VevaRX's terms and conditions state that transactions are conducted on a different company's website, and they list a set of prices that match nothing on the VevaRX product pages. Legal documents that describe another brand's storefront do not tell you what you are agreeing to.
- What is genuinely good about it?
- Three things. It enumerates thirty-six states by name rather than claiming all fifty, which is a stronger and checkable form of the claim. It states that the price is locked in before intake and holds at every dose, so the bill does not climb as you titrate. And the quoted price includes the provider visit, the supplies and free two-to-three-day shipping rather than adding them later.
Pricing, states and verification reflect VevaRX's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.